CIK 0001053369
- Non-accelerated filer
- Smaller reporting company
ELITE PHARMACEUTICALS INC /NV/
Sign in to watch- Ticker
- ELTP
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 223542636
- Phone
- +1 201-750-2646
- Business address
- 165 LUDLOW AVENUE, NORTHVALE, NJ, 07647
- Former names
- ELITE PHARMACEUTICALS INC /DE/
- 4 Grant or award Director acquired 58,475 shares (grant or award)
- 4 Grant or award Chairman of Board acquired 87,711 shares (grant or award)
- 4 Grant or award CFO, Secretary, Treasurer acquired 87,711 shares (grant or award)
- 4 Grant or award President & CEO acquired 2,046,554 shares (grant or award)
- 4 Conversion Chief Scientific Officer acquired 2,833,333 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO & President bought 700,000 shares at an average $0.31 ($216,341)
- 4 Conversion Chairman of the Board acquired 6,060,000 shares (conversion)
- 4 Derivatives Options or other derivatives
- 4 Conversion Director acquired 12,423 shares (conversion)
- 4/A Conversion Chairman of the Board acquired 375,000 shares (conversion)
- 4 Conversion Chairman of the Board acquired 375,000 shares (conversion)
- 4 Open-market sale Director sold 329,437 shares at $0.38 ($125,944)
- 4 Open-market sale Director sold 147,664 shares at $0.41 ($60,542)
- 4 Open-market sale Director sold 190,172 shares at $0.43 ($81,165)
- 4 Derivatives Options or other derivatives
Page 6 of 26 · 511 filings